-
1
-
-
0036488096
-
Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels
-
Simes J., Furberg C.D., Braunwald E., Davis B.R., Ford I., Tonkin A., and Shepherd J. Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. Eur. Heart J. 23 (2002) 207-2156
-
(2002)
Eur. Heart J.
, vol.23
, pp. 207-2156
-
-
Simes, J.1
Furberg, C.D.2
Braunwald, E.3
Davis, B.R.4
Ford, I.5
Tonkin, A.6
Shepherd, J.7
-
2
-
-
0027987849
-
-
The Scandinavian Simvastatin Survival Study Group, Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S), Lancet 344 (1994) 1383-1389.
-
The Scandinavian Simvastatin Survival Study Group, Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S), Lancet 344 (1994) 1383-1389.
-
-
-
-
3
-
-
0032572086
-
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study
-
Downs J.R., Clearfield M., Weis S., Whitney E., Shapiro D.R., Beere P.A., Langendorfer A., Stein E.A., Kruyer W., and Gottor Jr. A.M. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 279 (1998) 1615-1622
-
(1998)
JAMA
, vol.279
, pp. 1615-1622
-
-
Downs, J.R.1
Clearfield, M.2
Weis, S.3
Whitney, E.4
Shapiro, D.R.5
Beere, P.A.6
Langendorfer, A.7
Stein, E.A.8
Kruyer, W.9
Gottor Jr., A.M.10
-
4
-
-
0000306390
-
Statins do more than just lower cholesterol
-
Vaughan C.J., Murphy M.B., and Buckley B.M. Statins do more than just lower cholesterol. Lancet 348 (1996) 1079-1082
-
(1996)
Lancet
, vol.348
, pp. 1079-1082
-
-
Vaughan, C.J.1
Murphy, M.B.2
Buckley, B.M.3
-
5
-
-
0029155841
-
Disease-free intervals after partial ileal bypass in patients with coronary heart disease and hypercholesterolemia: report from the Program on the Surgical Control of the Hyperlipidemias (POSCH)
-
Buchwald H., Campos C.T., Boen J.R., Nguyen P.A., and Williams S.E. Disease-free intervals after partial ileal bypass in patients with coronary heart disease and hypercholesterolemia: report from the Program on the Surgical Control of the Hyperlipidemias (POSCH). J. Am. Coll. Cardiol. 26 (1995) 351-357
-
(1995)
J. Am. Coll. Cardiol.
, vol.26
, pp. 351-357
-
-
Buchwald, H.1
Campos, C.T.2
Boen, J.R.3
Nguyen, P.A.4
Williams, S.E.5
-
6
-
-
0035574650
-
In vivo anti-inflammatory effects of statins is mediated by nonsterol mevalonate products
-
Diomede L., Albani D., Sottocorno M., Donati M.B., Bianchi M., Fruscella P., and Salmona M. In vivo anti-inflammatory effects of statins is mediated by nonsterol mevalonate products. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1327-1332
-
(2001)
Arterioscler. Thromb. Vasc. Biol.
, vol.21
, pp. 1327-1332
-
-
Diomede, L.1
Albani, D.2
Sottocorno, M.3
Donati, M.B.4
Bianchi, M.5
Fruscella, P.6
Salmona, M.7
-
7
-
-
0030886472
-
Effects of fluvastatin on leukocyte-endothelial cell adhesion in hypercholesterolemic rats
-
Kimura M., Kurose I., Russel J., and Granger D.N. Effects of fluvastatin on leukocyte-endothelial cell adhesion in hypercholesterolemic rats. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 1521-1526
-
(1997)
Arterioscler. Thromb. Vasc. Biol.
, vol.17
, pp. 1521-1526
-
-
Kimura, M.1
Kurose, I.2
Russel, J.3
Granger, D.N.4
-
8
-
-
0034753831
-
A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid
-
Stalker T.J., Lefer A.M., and Scalia R. A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid. Br. J. Pharmacol. 133 (2001) 406-412
-
(2001)
Br. J. Pharmacol.
, vol.133
, pp. 406-412
-
-
Stalker, T.J.1
Lefer, A.M.2
Scalia, R.3
-
9
-
-
0344863177
-
Effects of pravastatin on chronic rejection of rat cardiac allografts
-
Maggard M.A., Ke B., Wang T., Kaldas F., Seu P., Busuttil R.W., and Imagawa D.K. Effects of pravastatin on chronic rejection of rat cardiac allografts. Transplantation 65 (1998) 149-155
-
(1998)
Transplantation
, vol.65
, pp. 149-155
-
-
Maggard, M.A.1
Ke, B.2
Wang, T.3
Kaldas, F.4
Seu, P.5
Busuttil, R.W.6
Imagawa, D.K.7
-
10
-
-
0035888090
-
Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis
-
Stanislaus R., Singh A.K., and Singh I. Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis. J. Neurosci. Res. 66 (2001) 155-162
-
(2001)
J. Neurosci. Res.
, vol.66
, pp. 155-162
-
-
Stanislaus, R.1
Singh, A.K.2
Singh, I.3
-
11
-
-
0036805674
-
Statins as anti-inflammatory agents
-
Weitz-Schmidt G. Statins as anti-inflammatory agents. Trends Pharmacol. Sci. 23 (2002) 482-486
-
(2002)
Trends Pharmacol. Sci.
, vol.23
, pp. 482-486
-
-
Weitz-Schmidt, G.1
-
12
-
-
0034607119
-
Cerivastatin suppresses lipopolysaccharide-induced ICAM-1 expression through inhibition of Rho GTPase in BAEC
-
Takeuchi S., Kawashima S., Rikitake Y., Ueyama T., Inoue N., Hirata K., and Yokoyama M. Cerivastatin suppresses lipopolysaccharide-induced ICAM-1 expression through inhibition of Rho GTPase in BAEC. Biochem. Biophys. Res. Commun. 269 (2000) 97-102
-
(2000)
Biochem. Biophys. Res. Commun.
, vol.269
, pp. 97-102
-
-
Takeuchi, S.1
Kawashima, S.2
Rikitake, Y.3
Ueyama, T.4
Inoue, N.5
Hirata, K.6
Yokoyama, M.7
-
13
-
-
0033584938
-
Integrin-dependent leukocyte adhesion involves geranylgeranylated protein(s)
-
Liu L., Moesner P., Kovach N.L., Bailey R., Hamilton A.D., Sebti S.M., and Harlan J.M. Integrin-dependent leukocyte adhesion involves geranylgeranylated protein(s). J. Biol. Chem. 274 (1999) 33334-33340
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 33334-33340
-
-
Liu, L.1
Moesner, P.2
Kovach, N.L.3
Bailey, R.4
Hamilton, A.D.5
Sebti, S.M.6
Harlan, J.M.7
-
14
-
-
0034948339
-
Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site
-
Weitz-Schmidt G., Weizenbach K., Brinkmann V., Kamata T., Kallen J., Bruns C., Cottens S., Takada Y., and Hommel U. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat. Med. 7 (2001) 687-692
-
(2001)
Nat. Med.
, vol.7
, pp. 687-692
-
-
Weitz-Schmidt, G.1
Weizenbach, K.2
Brinkmann, V.3
Kamata, T.4
Kallen, J.5
Bruns, C.6
Cottens, S.7
Takada, Y.8
Hommel, U.9
-
15
-
-
0028982203
-
Insulin-dependent diabetes mellitus as a beta-cell targeted disease of immunoregulation
-
Bach J.F. Insulin-dependent diabetes mellitus as a beta-cell targeted disease of immunoregulation. J. Autoimmun. 8 (1995) 439-463
-
(1995)
J. Autoimmun.
, vol.8
, pp. 439-463
-
-
Bach, J.F.1
-
16
-
-
34548858217
-
Simvastatin protects against multiple low-dose streptozotocin-induced type 1 diabetes in CD-1 mice and recurrence of disease in nonobese diabetic mice
-
Rydgren T., Vaarala O., and Sandler S. Simvastatin protects against multiple low-dose streptozotocin-induced type 1 diabetes in CD-1 mice and recurrence of disease in nonobese diabetic mice. J. Pharmacol. Exp. Ther. 323 (2007) 180-185
-
(2007)
J. Pharmacol. Exp. Ther.
, vol.323
, pp. 180-185
-
-
Rydgren, T.1
Vaarala, O.2
Sandler, S.3
-
17
-
-
0019135171
-
Insulin-dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: obligatory role of cell-mediated autoimmune processes
-
Paik S.G., Fleischer N., and Shin S.I. Insulin-dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: obligatory role of cell-mediated autoimmune processes. Proc. Natl. Acad. Sci. USA 77 (1980) 6129-6133
-
(1980)
Proc. Natl. Acad. Sci. USA
, vol.77
, pp. 6129-6133
-
-
Paik, S.G.1
Fleischer, N.2
Shin, S.I.3
-
18
-
-
0026546211
-
Prevention of autoimmune diabetes with nonactivating anti-CD3 monoclonal antibody
-
Herold K.C., Bluestone J.A., Montag A.G., Parihar A., Wiegner A., Gress R.E., and Hirsch R. Prevention of autoimmune diabetes with nonactivating anti-CD3 monoclonal antibody. Diabetes 41 (1992) 385-391
-
(1992)
Diabetes
, vol.41
, pp. 385-391
-
-
Herold, K.C.1
Bluestone, J.A.2
Montag, A.G.3
Parihar, A.4
Wiegner, A.5
Gress, R.E.6
Hirsch, R.7
-
19
-
-
0028916943
-
Diabetes induced with low doses of streptozotocin is mediated by V beta 8.2+ T-cells
-
Herold K.C., Bloch T.N., Vezys V., and Sun Q. Diabetes induced with low doses of streptozotocin is mediated by V beta 8.2+ T-cells. Diabetes 44 (1995) 354-359
-
(1995)
Diabetes
, vol.44
, pp. 354-359
-
-
Herold, K.C.1
Bloch, T.N.2
Vezys, V.3
Sun, Q.4
-
20
-
-
0034566966
-
Novel experimental strategies to prevent the development of type 1 diabetes mellitus
-
Sandler S., Andersson A.K., Barbu A., Hellerström C., Holstad M., Karlsson E., Sandberg J.O., Strandell E., Saldeen J., Sternesjö J., Tillmar L., Eizirik D.L., Flodström M., and Welsh N. Novel experimental strategies to prevent the development of type 1 diabetes mellitus. Ups. J. Med. Sci. 105 (2000) 17-34
-
(2000)
Ups. J. Med. Sci.
, vol.105
, pp. 17-34
-
-
Sandler, S.1
Andersson, A.K.2
Barbu, A.3
Hellerström, C.4
Holstad, M.5
Karlsson, E.6
Sandberg, J.O.7
Strandell, E.8
Saldeen, J.9
Sternesjö, J.10
Tillmar, L.11
Eizirik, D.L.12
Flodström, M.13
Welsh, N.14
-
21
-
-
0343048978
-
Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation
-
Wagner A.H., Köhler T., Rückschloss U., Just I., and Heckner M. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 61-69
-
(2000)
Arterioscler. Thromb. Vasc. Biol.
, vol.20
, pp. 61-69
-
-
Wagner, A.H.1
Köhler, T.2
Rückschloss, U.3
Just, I.4
Heckner, M.5
-
22
-
-
31544457088
-
Simvastatin protection against acute immune-mediated glomerulonephritis in mice
-
Christensen M., Su A.W., Snyder R.W., Greco A., Lipschutz J.H., and Madaio M.P. Simvastatin protection against acute immune-mediated glomerulonephritis in mice. Kidney Int. 69 (2006) 457-463
-
(2006)
Kidney Int.
, vol.69
, pp. 457-463
-
-
Christensen, M.1
Su, A.W.2
Snyder, R.W.3
Greco, A.4
Lipschutz, J.H.5
Madaio, M.P.6
-
23
-
-
0021927180
-
Modulation of streptozotocin-induced insulitis and hyperglycaemia in the mouse
-
Sandler S., and Andersson A. Modulation of streptozotocin-induced insulitis and hyperglycaemia in the mouse. Acta Pathol. Microbiol. Immunol. Scand. [A] 93 (1985) 93-98
-
(1985)
Acta Pathol. Microbiol. Immunol. Scand. [A]
, vol.93
, pp. 93-98
-
-
Sandler, S.1
Andersson, A.2
-
24
-
-
10444220208
-
Assessment of the efficacy of different statins in murine collagen-induced arthritis
-
Palmer G., Chobaz V., Talabot-Ayer D., Taylor S., So A., Gabay C., and Busso N. Assessment of the efficacy of different statins in murine collagen-induced arthritis. Arthritis Rheum. 50 (2004) 4051-4059
-
(2004)
Arthritis Rheum.
, vol.50
, pp. 4051-4059
-
-
Palmer, G.1
Chobaz, V.2
Talabot-Ayer, D.3
Taylor, S.4
So, A.5
Gabay, C.6
Busso, N.7
-
25
-
-
0037309378
-
A novel anti-inflammatory role for simvastatin in inflammatory arthritis
-
Leung B.P., Sattar N., Crilly A., Prach M., McCarey D.W., Payne H., Madhok R., Campbell C., Gracie J.A., Liew F.Y., and McInnes I.B. A novel anti-inflammatory role for simvastatin in inflammatory arthritis. J. Immunol. 170 (2003) 1524-1530
-
(2003)
J. Immunol.
, vol.170
, pp. 1524-1530
-
-
Leung, B.P.1
Sattar, N.2
Crilly, A.3
Prach, M.4
McCarey, D.W.5
Payne, H.6
Madhok, R.7
Campbell, C.8
Gracie, J.A.9
Liew, F.Y.10
McInnes, I.B.11
|